View Item 

Show simple item record

Periodontal Health in Women With Early‐Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study
dc.contributor.authorTaichman, L. Susan
dc.contributor.authorInglehart, Marita R.
dc.contributor.authorGiannobile, William V.
dc.contributor.authorBraun, Thomas
dc.contributor.authorKolenic, Giselle
dc.contributor.authorVan Poznak, Catherine
dc.date.accessioned2018-02-05T16:41:59Z
dc.date.available2018-02-05T16:41:59Z
dc.date.issued2015-07
dc.identifier.citationTaichman, L. Susan; Inglehart, Marita R.; Giannobile, William V.; Braun, Thomas; Kolenic, Giselle; Van Poznak, Catherine (2015). "Periodontal Health in Women With Early‐Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study." Journal of Periodontology 86(7): 906-916.
dc.identifier.issn0022-3492
dc.identifier.issn1943-3670
dc.identifier.urihttps://hdl.handle.net/2027.42/141857
dc.publisherWiley Periodicals, Inc.
dc.publisherAmerican Academy of Periodontology
dc.subject.otherAromatase inhibitors
dc.subject.otherpostmenopause
dc.subject.otherwomen’s health
dc.subject.otherperiodontal attachment loss
dc.subject.otherbreast neoplasms
dc.subject.otherbiological markers
dc.titlePeriodontal Health in Women With Early‐Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDentistry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Internal Medicine, Hematology and Oncology Division, University of Michigan.
dc.contributor.affiliationumCenter for Statistical Consultation and Research, University of Michigan.
dc.contributor.affiliationumDepartment of Biostatistics, School of Public Health, University of Michigan.
dc.contributor.affiliationumDepartment of Psychology; College of Literature, Science, and the Arts; University of Michigan.
dc.contributor.affiliationumDepartment of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI.
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141857/1/jper0906.pdf
dc.identifier.doi10.1902/jop.2015.140546
dc.identifier.sourceJournal of Periodontology
dc.identifier.citedreferenceEastell R. Aromatase inhibitors and bone. J Steroid Biochem Mol Biol 2007; 106: 157 – 161.
dc.identifier.citedreferenceWactawski‐Wende J, Hausmann E, Hovey K, Trevisan M, Grossi S, Genco RJ. The association between osteoporosis and alveolar crestal height in postmenopausal women. J Periodontol 2005; 76 (Suppl. 11): 2116 – 2124.
dc.identifier.citedreferenceHildebolt CF, Vannier MW, Shrout MK, et al. Periodontal disease morbidity quantification. II. Validation of alveolar bone loss measurements and vertical defect diagnosis from digital bite‐wing images. J Periodontol 1990; 61: 623 – 632.
dc.identifier.citedreferenceKrall EA. Osteoporosis and the risk of tooth loss. Clin Calcium 2006; 16: 287 – 290.
dc.identifier.citedreferencevon Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007; 370: 1453 – 1457.
dc.identifier.citedreferenceTaguchi A, Sanada M, Krall E, et al. Relationship between dental panoramic radiographic findings and biochemical markers of bone turnover. J Bone Miner Res 2003; 18: 1689 – 1694.
dc.identifier.citedreferenceNational Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology‐v.1 2010. Invasive breast cancer. Available at: http://www.nccn.org/professionals/physicians_gls/PDF/breast.pdf. Accessed December 17, 2014.
dc.identifier.citedreferencePowles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual‐energy x‐ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 1996; 14: 78 – 84.
dc.identifier.citedreferenceDuckworth JE, Judy PF, Goodson JM, Socransky SS. A method for the geometric and densitometric standardization of intraoral radiographs. J Periodontol 1983; 54: 435 – 440.
dc.identifier.citedreferenceRasband WS. ImageJ Image Processing and Analysis in Java software. Bethesda, MD: National Institutes of Health; 1997‐2014. Available at: http://imagej.nih.gov/ij/. Accessed March 3, 2013.
dc.identifier.citedreferenceMandel ID, Wotman S. The salivary secretions in health and disease. Oral Sci Rev 1976; 8: 25 – 47.
dc.identifier.citedreferenceCenters for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition Examination Protocol. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention; Available at: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm. Accessed August 29, 2014.
dc.identifier.citedreferenceLaMonte MJ, Hovey KM, Genco RJ, Millen AE, Trevisan M, Wactawski‐Wende J. Five‐year changes in periodontal disease measures among postmenopausal females: The Buffalo OsteoPerio study. J Periodontol 2013; 84: 572 – 584.
dc.identifier.citedreferenceBurstein HJ, Prestrud AA, Seidenfeld J, et al; American Society of Clinical Oncology. American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor‐positive breast cancer. J Clin Oncol 2010; 28: 3784 – 3796.
dc.identifier.citedreferenceColeman RE, Banks LM, Girgis SI, et al; Intergroup Exemestane Study group. Skeletal effects of exemestane on bone‐mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): A randomised controlled study. Lancet Oncol 2007; 8: 119 – 127.
dc.identifier.citedreferenceKanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 1999; 79: 1179 – 1181.
dc.identifier.citedreferencePayne JB, Reinhardt RA, Nummikoski PV, Patil KD. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 1999; 10: 34 – 40.
dc.identifier.citedreferencePilgram TK, Hildebolt CF, Dotson M, et al. Relationships between clinical attachment level and spine and hip bone mineral density: Data from healthy postmenopausal women. J Periodontol 2002; 73: 298 – 301.
dc.identifier.citedreferencePilgram TK, Hildebolt CF, Yokoyama‐Crothers N, et al. Relationships between longitudinal changes in radiographic alveolar bone height and probing depth measurements: Data from postmenopausal women. J Periodontol 1999; 70: 829 – 833.
dc.identifier.citedreferenceWalsh MC, Kim N, Kadono Y, et al. Osteoimmunology: Interplay between the immune system and bone metabolism. Annu Rev Immunol 2006; 24: 33 – 63.
dc.identifier.citedreferenceKatagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002; 8: 147 – 159.
dc.identifier.citedreferenceFolkestad L, Bjarnason NH, Bjerregaard JK, Brixen K. The effect of aromatase inhibitors on bone metabolism. Basic Clin Pharmacol Toxicol 2009; 104: 3 – 10.
dc.identifier.citedreferenceKwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL‐6, RANKL, TNF‐alpha/IL‐1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15: 49 – 60.
dc.identifier.citedreferenceLerner UH. Inflammation‐induced bone remodeling in periodontal disease and the influence of post‐menopausal osteoporosis. J Dent Res 2006; 85: 596 – 607.
dc.identifier.citedreferencePfeilschifter J, Köditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90 – 119.
dc.identifier.citedreferenceSzulc P. The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis. Clin Biochem 2012; 45: 907 – 919.
dc.identifier.citedreferenceTarkkila L, Kari K, Furuholm J, Tiitinen A, Meurman JH. Periodontal disease‐associated micro‐organisms in peri‐menopausal and post‐menopausal women using or not using hormone replacement therapy. A two‐year follow‐up study. BMC Oral Health 2010; 10: 10.
dc.identifier.citedreferenceJensen SB, Mouridsen HT, Bergmann OJ, Reibel J, Brünner N, Nauntofte B. Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 217 – 226.
dc.identifier.citedreferenceTaichman LS, Griggs JJ, Inglehart MR. Periodontal health, perceived oral health, and dental care utilization of breast cancer survivors (published online ahead of print February 3, 2015). J Public Health Dent. doi: 10.1111/jphd.12084.
dc.identifier.citedreferenceHenry NL, Pchejetski D, A’Hern R, et al. Inflammatory cytokines and aromatase inhibitor‐associated musculoskeletal syndrome: A case‐control study. Br J Cancer 2010; 103: 291 – 296.
dc.identifier.citedreferenceAmerican Cancer Society. Breast Cancer Facts & Figures 2009‐2010. Atlanta: American Cancer Society, Inc; 2009. Available at: http://www.cancer.org/cancer/breastcancer/detailedguide/breast‐cancer‐key‐statistics. Accessed August 22, 2014.
dc.identifier.citedreferenceRies LA, Keel GE, Eisner MP, Lin YD, Horner MJ. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988‐2001, Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, SEER Program; 2007. Available at: http://seer.cancer.gov/publications/survival. Accessed July 22, 2013.
dc.identifier.citedreferenceAnderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 2002; 76: 27 – 36.
dc.identifier.citedreferenceHowell A, Cuzick J, Baum M, et al; ATAC Trialists’ Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 2005; 365: 60 – 62.
dc.identifier.citedreferenceWiner EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor‐positive breast cancer: Status report 2004. J Clin Oncol 2005; 23: 619 – 629.
dc.identifier.citedreferenceEastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE; ATAC Trialists’ group. Effect of an aromatase inhibitor on BMD and bone turnover markers: 2‐year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). J Bone Miner Res 2006; 21: 1215 – 1223.
dc.identifier.citedreferenceEastell R, Adams JE, Coleman RE, et al. Effect of anastrozole on bone mineral density: 5‐year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 2008; 26: 1051 – 1057.
dc.identifier.citedreferenceLønning PE, Geisler J. Aromatase inhibitors — Socio‐economical issues. J Steroid Biochem Mol Biol 2005; 95: 137 – 142.
dc.identifier.citedreferencePerez EA, Josse RG, Pritchard KI, et al. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: A companion study to NCIC CTG MA.17. J Clin Oncol 2006; 24: 3629 – 3635.
dc.identifier.citedreferencevon Wowern N, Klausen B, Kollerup G. Osteoporosis: A risk factor in periodontal disease. J Periodontol 1994; 65: 1134 – 1138.
dc.identifier.citedreferenceBozic M, Ihan Hren N. Osteoporosis and mandibles. Dentomaxillofac Radiol 2006; 35: 178 – 184.
dc.identifier.citedreferenceWhite SC, Atchison KA, Gornbein JA, et al. Change in mandibular trabecular pattern and hip fracture rate in elderly women. Dentomaxillofac Radiol 2005; 34: 168 – 174.
dc.identifier.citedreferenceOlin JL, St Pierre M. Aromatase inhibitors in breast cancer prevention. Ann Pharmacother 2014; 48: 1605 – 1610.
dc.identifier.citedreferenceTezal M, Wactawski‐Wende J, Grossi SG, Dmochowski J, Genco RJ. Periodontal disease and the incidence of tooth loss in postmenopausal women. J Periodontol 2005; 76: 1123 – 1128.
dc.identifier.citedreferenceWactawski‐Wende J. Periodontal diseases and osteoporosis: Association and mechanisms. Ann Periodontol 2001; 6: 197 – 208.
dc.identifier.citedreferenceHildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol 1997; 26: 3 – 15.
dc.identifier.citedreferenceMiller CS, King CP Jr., Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: A cross‐sectional study. J Am Dent Assoc 2006; 137: 322 – 329.
dc.identifier.citedreferenceRamseier CA, Kinney JS, Herr AE, et al. Identification of pathogen and host‐response markers correlated with periodontal disease. J Periodontol 2009; 80: 436 – 446.
dc.identifier.citedreferenceKinney JS, Morelli T, Braun T, et al. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res 2011; 90: 752 – 758.
dc.identifier.citedreferenceTezal M, Wactawski‐Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000; 71: 1492 – 1498.
dc.identifier.citedreferenceWactawski‐Wende J, Grossi SG, Trevisan M, et al. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996; 67 (Suppl. 10): 1076 – 1084.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jper0906.pdf
Size:
643.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.